我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

同型半胱氨酸与心血管疾病关系的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2000年第3期
页码:
216-218
栏目:
综述
出版日期:
2000-05-25

文章信息/Info

Title:
-
作者:
蒋珍妮;  俞锋
浙江医科大学附属第二医院， 浙江 杭州 310009
Author(s):
-
关键词:
同型半胱胺酸; 心血管疾病; 危险因子
Keywords:
-
分类号:
Q517
DOI:
-
文献标识码:
A
摘要:
同型半胱氨酸是蛋氨酸代谢过程中产生的一种含硫氨基酸,其血浆浓度增高与心血管疾病密切相关,可能是致动脉粥样硬化的一种独立危险因子。
Abstract:
-

参考文献/References

［1］Boushey CJ,Beresford SAA, Omen GS,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disaese［J］. JAMA,1995;274:1049.

［2］　Kong SS,Wong PWR,Becker N,et al. Proteint-bound homocysteine in normal subjects and in patients with homocystinuria［J］. Pediatr Res,1979;13:1141.

［3］　Refsum H,Helland S,Ueland PM,et al. Radioenzyemic determination of homocysteine in plasma and urine［J］. Clin Chem,1985;31:624.

［4］　Jacobsen DW,Gatautis VJ,Green R,et al. Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection［J］. Anal Biochem,1989;178:208.

［5］　Gerritsen J,James G,Vaughn and Waisman HA,et al. The identification of homocysteine in the urine［J］. Biochem Biophy Res Commun,1962;9:493.

［6］　Jacobsen DW,Gatautis VJ,Green R,et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma［J］. Clin Chem,1994;40(6):873.

　　［7］　Ueland PM,Refesum H,Stabler SP,et al. Total homocysteine in plasma or serum:methods and clinical applications［J］. Clin Chem,1993;39(9):1764.

［8］　Moller J,Karsten Rasmussen. Homocysteine in Plasma:stabilization of blood samples with fluoride［J］. Clin Chem,1995;41(5):758.

［9］　Robinson K,Arheart K,Refusum H,et al. Low circulating folate and vitamin B6 concentrations:risk factors for stroke,peripheral vascular disease,and coronary artery disease［J］. Girculation,1998;97(5):437.

［10］　Alfthan G,Antti Aro,Gey KF,et al. Plasma homocysteine and cardiovascular disease mortality［J］. Lancet,1997;349:347.

［11］　Franco RF, Araujo AG,Guerreiro JF,et al. Analysis of the 677C→T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups［J］. Thromb Haemost,1998;791:119.

［12］　Montalescot G,Ankri A,Blacher J,et al. Plasma homocysteine and the extent of atherosclerrosis in patients with coronary artery disease［J］. Int J Cardiol,1997;60(3):295.

［13］　Woo KS,Chook P,Loline YI,et al. Hyperhomocysteinemia is a risk factor for arterial endothelia dysfunction in human［J］. Circulation,1997;96(8):2542.

［14］　Graham IM,Daly LE,Refusum H,et al. Plasma homocysteine as a risk factor for vascular disease［J］. JAMA,1997;277(22):1775.

［15］　Hoogeveen EK,Kostense PJ,Beks PJ,et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease,especially in non-insulin-dependent diabetes mellitus:a popular-based study［J］. Arterioscler,Thromb Vasc Biol,1998;18(1):133.

［16］　Gibelin P,Candito M,Houenassi M,et al. Blood levels of homocysteine in patients under 55 years of age with acute coronary insufficiency［J］. Presse Med,1997;26(30):1425.

［17］　Malinow MR,Nicto FJ,Szklo M,et al. Carotid artery intimalmedial wall thickening and plasma homocysteine in asymptomatic adults［J］. Circulation,1993;87:1107.

［18］　Malinow MR. Plasma homocysteine and arterial occlusive disease［J］. Clin Chem,1994;41(1):173.

［19］　Boers GHJ,Smals AGH,Trijbels FJM,et al. Heterzygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease［J］. N Engl J Med,1985;313:709.

［20］　Coull BM,Malinow MR,NancyBeamer MS,et al. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke［J］. Stroke,1990;21:572.

［21］　Stampfer MJ,Malinow MR Willett WC,et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicins［J］. JAMA,1992;268:877.

［22］　Berwanger CS,Jereny JY,Stansby C,et al. Homocysteine and vascular disease［J］. Br J Sur,1995;82(6):726.

［23］　Stamler JS,Osborne JA,Omar Jaraki,et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen［J］. J Clin Invest,1993;91:308.

［24］　Nygard O,Vollset SE,Refsum H,et al. Total plasma homocysteine and cardiovascular risk profile［J］. JAMA,1995;274(19):1526.

［25］　Marlinow MR, Kang SS,Taylor LM,et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease［J］. Circulation,1989;79:1180.

［26］　Rodgers GM,Conn MT. Homocysteine,an atherogenic stimulus,reduces protein C activation by arterial and venous endothelia cells［J］. Blood,1990;75(4):895.

［27］　Lily LW,James W,Steven CH,et al. Plasma homocysteine as a risk factor for early family coronary artery disease［J］. Clin Chem,1994;40(4):552.

［28］　Ubbink J,Vermark W,Van der Merwe A,et al. Vitamin B12,Vitmin B6 and folate nutritional status in men with hyperhomocysteinemia［J］. Am J Clin Nutr,1993;57:47.

［29］　Ward M,McNulty HJ,McPartlin,et al. Plasma homocysteine,a risk factor for cardiovascular disease,is lowered by physiologycal dose of folicacid［J］. Q J Med,1997;90(8):519.

［30］　Franken DG,Godfried HJ,Boers,Henk JB,et al. Treatment of mild hyperhomocysteinemia in vascular disease patients［J］. Arterioscler Thromb Vasc Biol,1994;14(3):465.

备注/Memo

备注/Memo:
收稿日期：1999-02-25.
更新日期/Last Update: 2000-05-25